While biologic therapies have revolutionized RA treatment, this case demonstrates their potential complications, highlighting the importance of vigilant monitoring and alternative approaches like rituximab for refractory cases, though further research is needed to understand the mechanisms of TNF inhibitor-induced vasculitis and develop optimal management strategies for this rare complication. The gene discussed is TNF; the disease is rheumatoid arthritis.